Alnylam to Webcast Presentations at Upcoming November Investor Conferences

BusinesswireNov 4 21:00

H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400

Futu NewsNov 4 19:31 · Ratings

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

BenzingaNov 4 19:16 · Ratings

A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $371

Futu NewsNov 2 21:00 · Ratings

Barclays Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $329

BenzingaNov 1 21:46 · Ratings

A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $300 to $384

Futu NewsNov 1 21:00 · Ratings